Viewing Study NCT05073003


Ignite Creation Date: 2025-12-24 @ 7:42 PM
Ignite Modification Date: 2026-02-25 @ 4:56 PM
Study NCT ID: NCT05073003
Status: COMPLETED
Last Update Posted: 2025-12-04
First Post: 2021-09-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-10-06
Start Date Type: ACTUAL
Primary Completion Date: 2025-06-24
Primary Completion Date Type: ACTUAL
Completion Date: 2025-06-24
Completion Date Type: ACTUAL
First Submit Date: 2021-09-29
First Submit QC Date: None
Study First Post Date: 2021-10-11
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-27
Last Update Post Date: 2025-12-04
Last Update Post Date Type: ESTIMATED